Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10 - PubMed (original) (raw)
Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10
C Burkhart et al. Int Immunol. 1999 Oct.
Abstract
Experimental autoimmune encephalomyelitis (EAE) is a CD4(+) T cell-mediated, inflammatory disease with similarities to multiple sclerosis in humans. Intranasal (i.n.) administration of a myelin basic protein (MBP)-derived peptide can protect susceptible mice from EAE. The mechanisms underlying this phenomenon, however, remain unclear. To analyze the phenotypic and functional changes taking place during the induction of tolerance by peptide inhalation, we have studied the fate of CD4(+) T cells after i.n. peptide application using transgenic mice expressing a TCR specific for the N-terminal peptide (Ac1-9) of MBP. Peripheral T cell death was variably observed in TCR transgenic mice after a single i.n. administration of antigenic peptide but was transient and incomplete. Transgenic spleen cells and cervical lymph node cells responded with a cytokine burst to peptide inhalation and hyperproliferation when re-stimulated in vitro. Transfer experiments demonstrated that the duration of peptide administration required to induce tolerance depended on the precursor frequency of T cells in recipient animals. The stringency of i.n. peptide treatment was increased so as to test the efficacy of tolerance induction both in vitro and in vivo in the presence of high precursor frequencies of antigen-specific T cells. Multiple i.n. doses of peptide completely protected TCR transgenic mice from EAE induced with myelin. Such repeated peptide administration resulted in down-regulation of the capacity of antigen-specific CD4(+) T cells to proliferate or to produce IL-2, IFN-gamma and IL-4 but increased the production of IL-10. The role of IL-10 in suppression of EAE in vivo was demonstrated by neutralization of IL-10. This completely restored susceptibility to EAE in mice previously protected by i.n. peptide. Considering the immunosuppressive properties of IL-10, T cells which are resistant to apoptosis might act as regulatory cells and mediate bystander suppression.
Similar articles
- Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
Chen Y, Inobe J, Kuchroo VK, Baron JL, Janeway CA Jr, Weiner HL. Chen Y, et al. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):388-91. doi: 10.1073/pnas.93.1.388. Proc Natl Acad Sci U S A. 1996. PMID: 8552644 Free PMC article. - Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ, Bai XF, Shi FD, Xiao BG, Li HL, Levi M, Mustafa M, Wahren B, Link H. Liu JQ, et al. Int Immunol. 1998 Aug;10(8):1139-48. doi: 10.1093/intimm/10.8.1139. Int Immunol. 1998. PMID: 9723700 - Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.
Li HL, Liu JQ, Bai XF, vn der Meide PH, Link H. Li HL, et al. Immunology. 1998 Jul;94(3):431-7. doi: 10.1046/j.1365-2567.1998.00526.x. Immunology. 1998. PMID: 9767428 Free PMC article. - Treatment of autoimmune disease by oral tolerance to autoantigens.
Whitacre CC, Gienapp IE, Meyer A, Cox KL, Javed N. Whitacre CC, et al. Clin Immunol Immunopathol. 1996 Sep;80(3 Pt 2):S31-9. doi: 10.1006/clin.1996.0139. Clin Immunol Immunopathol. 1996. PMID: 8811061 Review. - Oral tolerance in experimental autoimmune encephalomyelitis.
Whitacre CC, Gienapp IE, Meyer A, Cox KL, Javed N. Whitacre CC, et al. Ann N Y Acad Sci. 1996 Feb 13;778:217-27. doi: 10.1111/j.1749-6632.1996.tb21130.x. Ann N Y Acad Sci. 1996. PMID: 8610975 Review.
Cited by
- Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity.
Richardson N, Wraith DC. Richardson N, et al. Immunother Adv. 2021 May 22;1(1):ltab009. doi: 10.1093/immadv/ltab009. eCollection 2021 Jan. Immunother Adv. 2021. PMID: 35919740 Free PMC article. Review. - Induction of Tolerance to Therapeutic Proteins With Antigen-Processing Independent T Cell Epitopes: Controlling Immune Responses to Biologics.
Schurgers E, Wraith DC. Schurgers E, et al. Front Immunol. 2021 Sep 9;12:742695. doi: 10.3389/fimmu.2021.742695. eCollection 2021. Front Immunol. 2021. PMID: 34567009 Free PMC article. Review. - Antigen-specific immunotherapy with apitopes suppresses generation of FVIII inhibitor antibodies in HLA-transgenic mice.
Pletinckx K, Nicolson KS, Streeter HB, Sanderson WJ, Schurgers E, Jansson L, Wraith DC. Pletinckx K, et al. Blood Adv. 2022 Apr 12;6(7):2069-2080. doi: 10.1182/bloodadvances.2021004451. Blood Adv. 2022. PMID: 34529764 Free PMC article. - The Mechanism of Action of Antigen Processing Independent T Cell Epitopes Designed for Immunotherapy of Autoimmune Diseases.
Shepard ER, Wegner A, Hill EV, Burton BR, Aerts S, Schurgers E, Hoedemaekers B, Ng STH, Streeter HB, Jansson L, Wraith DC. Shepard ER, et al. Front Immunol. 2021 Apr 14;12:654201. doi: 10.3389/fimmu.2021.654201. eCollection 2021. Front Immunol. 2021. PMID: 33936079 Free PMC article. Review. - Non-Genetically Encoded Epitopes Are Relevant Targets in Autoimmune Diabetes.
Nguyen H, Guyer P, Ettinger RA, James EA. Nguyen H, et al. Biomedicines. 2021 Feb 17;9(2):202. doi: 10.3390/biomedicines9020202. Biomedicines. 2021. PMID: 33671312 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous